CORNERSTONE GENOMICS INC

Cornerstone Genomics Inc. specializes in advanced genomic data analysis and bioinformatics support for federal research and public health initiatives. Their core capabilities include high-throughput sequencing data processing, variant calling pipelines, NGS data interpretation, and computational biology tool development, with a focus on translating complex genomic datasets into actionable biological insights. The company brings deep expertise in bioinformatics software engineering, cloud-based genomic workflows, and compliance with NIH and FDA data standards, ensuring reproducible, auditable analyses for sensitive research environments. Their technical differentiation lies in integrating machine learning models with clinical genomics pipelines and maintaining strict adherence to HIPAA and GDPR-aligned data governance frameworks. While award history is not available to confirm specific agency engagements, the contractor’s technical profile suggests alignment with research-focused federal entities such as NIH, CDC, and DOD biomedical programs, where genomic sequencing and precision medicine initiatives are prioritized. Their work likely supports population health studies, infectious disease surveillance, and personalized therapeutics development through secure, scalable data infrastructure. The primary NAICS code 541690—Other Scientific and Technical Consulting Services—reflects a consulting model centered on applied genomics and computational biology, positioning Cornerstone Genomics as a niche provider of specialized scientific services rather than broad IT infrastructure. They serve verticals including biomedical research, public health surveillance, and defense medical innovation, emphasizing evidence-based decision support through data-driven genomics. As a Women-Owned Small Business and Woman-Owned Business certified entity headquartered in Sharpsburg, MD, Cornerstone Genomics operates as a small, agile firm with a focused mission in life sciences consulting. Their certifications enhance access to set-aside opportunities and signal commitment to diversity in STEM-driven federal contracting. The company’s geographic presence in Maryland places it within a major biotech and federal research corridor, reinforcing its strategic alignment with national health and science priorities.